Search

Your search keyword '"Malecka-Panas, E."' showing total 184 results

Search Constraints

Start Over You searched for: Author "Malecka-Panas, E." Remove constraint Author: "Malecka-Panas, E."
184 results on '"Malecka-Panas, E."'

Search Results

1. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

2. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

6. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study

8. Association of genetic variants affecting microRNAs and pancreatic cancer risk

9. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (reappear): Protocol of a randmozied controlled trial and a cohort study

10. Common variants in glyoxalase I do not inease chronic pancreatitis risk

11. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

12. Analysis of GPRC6A variants in different pancreatitis etiologies

14. Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment

16. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma

17. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

18. Common variants in glyoxalase I do not increase chronic pancreatitis risk

20. Corrigendum: Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms [Carcinogenesis, 39, 3, (2018), (360-367)] DOI: 10.1093/carcin/bgx150

21. SLC22A3 polymorphisms may influence overall patient survival-PANDORA study

22. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms

23. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation

25. EU Pancreas: An Integrated European Platform for Pancreas Cancer Research - from Basic Science to Clinical and Public Health Interventions for a Rare Disease

26. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

27. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

28. Identification of recessively inherited genetic variants for pancreatic cancer risk

29. Association of variants of genes involved in mitochondrial metabolism with pancreatic cancer risk

30. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation

31. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

33. ROLE OF ADIPOKINES IN THE ASSESSMENT OF SEVERITY AND PREDICTING THE CLINICAL COURSE OF ACUTE PANCREATITIS.

34. CLINICAL SIGNIFICANCE OF ACTIVIN A AND MYOSTATIN IN PATIENTS WITH PANCREATIC ADENOCARCINOMA AND PROGRESSIVE WEIGHT LOSS.

35. Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma

36. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors

37. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

38. Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

39. Polymorphism of taste receptor genes (TASRs) and risk of pancreatic cancer

40. Ustekinumab as induction and maintenance therapy for Crohn's disease

41. Umfangreiche epidemiologische und Genotyp-Phänotyp (GxP) Analysen in dem weltweit größten Patientenkollektiv mit idiopathischer Achalasie

44. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study

45. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

46. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

47. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Catalog

Books, media, physical & digital resources